✦ LIBER ✦

Surgical outcomes after cardiac surgery in liver transplant recipients

✍ Scribed by Ota, Takeyoshi; Rocha, Rodolfo; Wei, Lawrence M.; Toyoda, Yoshiya; Gleason, Thomas G.; Bermudez, Christian

Book ID: 122530431
Publisher: CTSNet
Year: 2013
Tongue: English
Weight: 145 KB
Volume: 145
Category: Article
ISSN: 1097-685X
DOI: 10.1016/j.jtcvs.2012.09.099

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cardiac Surgery in Kidney and Liver Tran

Cardiac Surgery in Kidney and Liver Transplant Recipients

✍ Deb, Subrato J.; Mullany, Charles J.; Kamath, Patrick S.; Dearani, Joseph A.; Da 📂 Article 📅 2006 🏛 Mayo Clinic 🌐 English ⚖ 76 KB

Aspergillus fumigatus endocarditis in a

Aspergillus fumigatus endocarditis in a pediatric liver transplant recipient: Favorable outcome without cardiac surgery

✍ Olivia Mourier; Philippe Durand; Virginie Lambert; Stéphane Bretagne; Chantal Ma 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 174 KB

Cardiac surgery in renal transplant reci

Cardiac surgery in renal transplant recipients

✍ Y Kobayashi; N Fukushima; S Ohtake; Y Sawa; M Nishimura; N Hirata; S Taketani; Y 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 140 KB

Surgical complications after liver trans

Surgical complications after liver transplantation in 67 Egyptian recipients

✍ H Khalaf 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 68 KB

Perioperative outcomes of cardiac surger

Perioperative outcomes of cardiac surgery in kidney and kidney–pancreas transplant recipients

✍ Ranjit John; Katherine Lietz; Stephen Huddleston; Arthur Matas; Kenneth Liao; Sa 📂 Article 📅 2007 🏛 CTSNet 🌐 English ⚖ 119 KB

Outcomes of acute rejection after interf

Outcomes of acute rejection after interferon therapy in liver transplant recipients

✍ Sammy Saab; Denise Kalmaz; Nupoor A. Gajjar; Jonathan Hiatt; Francisco Durazo; S 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 229 KB 👁 1 views

Interferon alfa has been increasingly used against recurrent hepatitis C (HCV) disease in post-liver transplant (LT) recipients. A serious potential adverse effect is acute rejection. We reviewed our experience using interferonbased therapy (interferon or pegylated interferon with or without ribavir